While the cure rate of children with Burkitt lymphoma is approximately 90% in higher-income countries, only 20%–70% of children with these diseases are cured in lower- or middle-income countries.
Twice-weekly administration of carfilzomib requires patients to receive carfilzomib infusions on 2 consecutive days each week.
The Guardant360 assay is as effective as traditional tumor-based genotyping assays in identifying genomic alterations, according to researchers.
The efficacy and safety of autologous hematopoietic stem cell transplantation (auto-HCT) performed during the era of novel agents was comparable between elderly and younger patients with multiple myeloma, according to results of a retrospective study published in Bone Marrow Transplantation. Uncertainty remains regarding the risks and benefits of auto-HCT in elderly patients (≥ 65 years).…
A retrospective study of patients with gastric cancer in the United States showed differences in patient- and disease-related characteristics, as well as different frequencies of staging laparoscopy, treatment/surgical approaches, and specific clinical outcomes, for those of Hispanic compared with non-Hispanic ethnicity. This study was published in the Journal of Surgical Oncology. In the US, the incidence of gastric…
A significant linear relationship was observed in a study investigating whether the proportion of female membersacross National Comprehensive Cancer Network (NCCN) guideline panels correlated with the proportion of female authors of seminal treatment-related publications cited in those guidelines. This study was published online in Lancet Oncology. Studies exploring barriers to the advancement of women in academic medicine…
A case report describing the diagnosis of anaplastic large cell lymphoma (ALCL) in a woman who underwent cosmetic placement of bilateral, textured silicone gluteal implants was published online in Aesthetic Surgery Journal. 1 The US Food and Drug Administration (FDA) recently issued an update regarding the number of reported cases of breast implant-associated ALCL (BIA-ALCL), a rare form of…
This study was presented at the 2019 International Congress on Targeted Anticancer Therapies (TAT) in Paris, France, from February 25-27, 2019. Dr Jun Sato of the National Cancer Center Hospital, Japan is the lead author of this study.1 Results from a retrospective study evaluating the focus of early-phase clinical trials of investigational drug candidates in…
